drugset / Trial / NCT03320772

TMVP1-ICG Mapping in Laparoscopic SLN Detection in Cervical Cancer

NCT03320772 ↗

Phase 1 Unknown 40 enrolled Huazhong University of Science and Technology
RandomizedParallel-groupOpen-labelDiagnostic

Summary

Sentinel lymph node (SLN) mapping is an acceptable surgical strategy determine whether to perform radical lymphadenectomy in patients with early-stage cervical cancer. Investigators aim to determine the validity of this technique with our novel tumor targeted fluorescent TMVP1-ICG to increased accuracy of SLN mapping.

Timeline

Start
2017-05-01
Primary completion
2018-05
Completion
2019-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator ICG Diagnostic / imaging agent 0.4 ml Other
Comparator ICG Diagnostic / imaging agent 1 mg/ml Other
Subject TMVP1-ICG Diagnostic / imaging agent 0.4 ml Other
Subject TMVP1-ICG Diagnostic / imaging agent 1 mg/ml Other

Indications